Completed PHASE3 INTERVENTIONAL NCT00334399

Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide

Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.

Interventions Miglitol

Updated 6 times since 2017 Last updated: Oct 8, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Type 2 Diabetes Mellitus, this trial is completed. The trial is conducted by Sanwa Kagaku Kenkyusho Co., Ltd. and has accumulated 6 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Sanwa Kagaku Kenkyusho Co., Ltd.

Data source: Sanwa Kagaku Kenkyusho Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aichi, Japan , Chiba, Japan , Fukuoka, Japan , Gifu, Japan , Gunma, Japan , Hokkaido, Japan , Ibaraki, Japan , Kanagawa, Japan , Kumamoto, Japan , Miyazaki, Japan and 3 more locations